| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.13B | +9.7% |
| R&D Expense | $177.6M | +11.9% |
| SG&A Expense | $180.2M | -1.2% |
| Operating Income | $1.71B | +12.1% |
| Pre-tax Income | $1.49B | +10.2% |
| Income Tax | $292.0M | +18.2% |
| Net Income | $1.20B | +8.4% |
| EPS (Basic) | $15.72 | +11.6% |
| EPS (Diluted) | $15.69 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $515.3M | +25.9% |
| Current Assets | $1.64B | +22.4% |
| Total Assets | $5.70B | +4.7% |
| Current Liabilities | $1.83B | +15.4% |
| Long-term Debt | $6.20B | +37.5% |
| Total Liabilities | $8.36B | +30.9% |
| Stockholders' Equity | -$2.65B | -182.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.59B | +5.8% |
| Capital Expenditures | $39.3M | +16.5% |
| Investing Cash Flow | -$130.1M | +9.8% |
| Financing Cash Flow | -$1.36B | +2.9% |
| Free Cash Flow | $1.55B | +5.5% |
| +11.7% |